摘要: Summary of change in the 3.2013 version of the Guidelines for the Colon Cancer from the 1.2013 version include: COL-C 3 of 9 FOLFOX and Capeox added as treatment options in therapy after second prog ...
Summary of change in the 3.2013 version of the Guidelines for the Colon Cancer from the 1.2013 version include:
COL-C 3 of 9
FOLFOX and Capeox added as treatment options in therapy after second progression for patients treated previously with irinotecan-based chemotherapy.
